Differential associations of circulating peroxiredoxins levels with indicators of glycemic control in type 2 diabetes mellitus

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 5, 2014, Pages 710-716

  Al Masri, A A ^a   El Eter, E ^a,b   Tayel, S ^a   Zamil, H ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

Glycemic control; Oxidative stress; Peroxiredoxins; Type 2 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; BIOLOGICAL MARKER; GLUCOSE; HEMOGLOBIN A1C; INSULIN; PEROXIREDOXIN 1; PEROXIREDOXIN 2; PEROXIREDOXIN 4; PEROXIREDOXIN 6; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; PEROXIREDOXIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; CLINICAL LABORATORY; CONTROLLED STUDY; DIABETIC PATIENT; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE DURATION; ELISA KIT; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMATOLOGY ANALYZER; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; BLOOD; DIABETES MELLITUS, TYPE 2; GLYCEMIC INDEX; METABOLISM; PHYSIOLOGY;

ADULT; AGED; BIOMARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GLYCEMIC INDEX; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; OXIDATIVE STRESS; PEROXIREDOXINS;

EID: 84897016805     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. CERIELLO A. New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy. Diabetes Care 2003; 26: 1589-1596.
2. FRIDLYAND LE, PHILIPSON LH. Reactive species and early manifestation of insulin resistance in type 2 diabetes. Diabetes Obes Metab 2006; 8: 136-145.
3. NIEDOWICZ DM, DALEKE DL. The role of oxidative stress in diabetic complications. Cell Biochem Biophysics 2005; 43: 289-330.
4. REHMAN A, NOUROOZ-ZADEH J, MOLLER W, TRITSCHLER H, PEREIRA P, HALLIWELL B. Increased oxidative damage to all DNA bases in patients with type II diabetes mellitus. FEBS Lett 1999; 448: 120-122.
5. MOHAMED AK, BIERHAUS A, SCHIEKOFER S, TRITSCHLER H, ZIEGLER R, NAWROTH PP. The role of oxidative stress and NF-kappa B activation in late diabetic complications. Biofactors 1999; 10: 157-167.
6. DANDONA P, ALJADA A, BANDYOPADHYAY A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 2004; 25: 4-7.
7. FESTA A, D'AGOSTINO R, HOWARD G, MYKKÄNEN L, TRACY RP, HAFFNER SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS) Circulation 2000; 102: 42-47.
8. WIERUSZ-WYSOCKA B, WYSOCKI H, BYKS H, ZOZULINSKA D, WYKRETOWICZ A, KAZMIERCZAK M. Metabolic control quality and free radical activity in diabetic patients. Diabetes Res Clin Pract 1995; 27: 193-197.
9. SHARMA A, KHARB S, CHUGH SN, KAKKAR R, SINGH GP. Evaluation of oxidative stress before and after control of glycemia and after vitamin E supplementation in diabetic patients. Metabolism 2000; 49: 160-162.
10. BERGAMINI CM, GAMBETTI S, DONDI A, CERVELLATI C. Oxygen, reactive oxygen species and tissue damage. Curr Pharm Des 2004; 10: 1611-1626.
11. RHEE SG, CHAE HZ, KIM K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 2005; 38: 1543-1552.
12. JANG HH, LEE KO, CHI YH, JUNG BG, PARK SK, PARK JH, LEE JR, LEE SS, MOON JC, YUN JW, CHOI YO, KIM WY, KANG JS, CHEONG CW, YUN DJ, RHEE SG, CHO MJ, LEE SY. Two enzymes in one; two yeast peroxiredoxins display oxidative stress-dependent switching from a peroxidase to a molecular chaperone function. Cell 2004: 117: 625-635.
13. BHATIA S, SHUKLA R, VENKATA MADHU S, KAUR GAMBHIR J, MADHAVA PRABBU K. Antioxidant status, lipid peroxidation and nitric oxide endproducts in patients of type 2 diabetes mellitus with nephropathy. Clin Biochem 2003; 36: 557-562.
14. MEMISOGULLARI R, TAYSI S, BAKAN E, CAPOGLU I. Antioxidant status and lipid peroxidation in type II diabetes mellitus. Cell Biochem Funct 2003; 21: 291-296.
15. BRINKMANN C, NEUMANN E, BLOSSFELD J, FRESE S, ORTHMANN P, MONTIEL G, BLOCH W, BRIXLUS K. Infleunce of glycemic status and physical fitness on oxidative stress and peroxiredoxin system in the erythrocytes of non-insulin dependent type 2 diabetic men. Exp Clin Endocrinol Diabetes 2011; 119: 559-564.
16. BRINKMANN C, BLOSSFELD J, PESCH M, KRONE B, WIESIOLLEK K, CAPIN D, MONTIEL G, HELLMICH M, BLOCH W, BRIXIUS K. Lipid peroxidation and peroxiredoxinoveroxidation in the erythrocytes of non-insulindependent type 2 diabetic men during acute exercise. Eur J Appl Physiol 2012; 112: 2277-2287.
17. MATTHEWS DR, HOSKER JP, RUDENSKI AS, NAYLOR BA, TREACHER DF, TURNER RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
18. JEFFCOATE SL. Diabetes control and complications: the role of glycated hemoglobin, 25 years on. Diabet Med 2004; 21: 657-665.
19. KASZNICKI J, KOSMALSKI K, SLIWINSKA A, MROWICKA M, STANCZYK M, MAJSTEREK I, DRZEWOSKI J. Evaluation of oxidative stress markers in pathogenesis of diabetic neuropathy. Mol Biol Reports 2012; 39: 8669-8678.
20. SAVU O, IONESCU-TIRGOVISTE C, ATANASIU V, GAMAN L, PAPACOCEA R, STOIAN I. Increase in total antioxidant capacity of plasma despite high levels of oxidative stress in uncomplicated type 2 diabetes mellitus. J Inter Med Res 2012; 40: 709-716.
21. MAECHLER P, JORNOT L, WOLLHEIM CB. Hydrogen peroxide alters mitochondrial activation and insulin secretion in pancreatic beta cells. J Biol Chem 1999; 274: 27905-27913.
22. MAXWELL SR, THOMASON H, SANDLER D, LE GUEN C, BAXTER MA, THORPE GH, JONES AF, BARNETT AH. Poor glycemic control is associated with reduced serum free radical scavenging (antioxidant) activity in non-insulin-dependent diabetes mellitus. Ann Clin Biochem 1997; 34: 628-644.
23. YANG Z, LAUBACH VE, FRENCH BA, KRON IL. Acute hyperglycemia enhances oxidative stress and exacerbates myocardial infarction by activating nicotinamide adenine dinucleotide phosphate oxidase during reperfusion. J Thoracic Cardiovasc Surg 2009; 137: 723-729.
24. EVANS JL, GOLDFINE ID, MADDUX BA, GRODSKY GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 2002; 23: 99-622.
25. RAMASAMY R, VANNUCCI SJ, YAN SSD, HEROLD K, YAN SF, SCHMIDT AM. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 2005; 15: 16R-28R.
26. CERIELLO A, MOTZ E, CAVARAPE A LIZZIO S, RUSSO A, QUARARO A, GIUGLIANO D. Hyperglycemia counterbalances the antihyper tensive effect of glutathione in diabetic patients: evidence linking hypertension and glycemia through the oxidative stress in diabetes mellitus. J Diabetes Complications 1997; 11: 250-255.